Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Purchased by Teacher Retirement System of Texas

Teacher Retirement System of Texas raised its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 17.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 14,682 shares of the company’s stock after purchasing an additional 2,224 shares during the period. Teacher Retirement System of Texas’ holdings in Prestige Consumer Healthcare were worth $1,147,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in PBH. Martingale Asset Management L P increased its stake in shares of Prestige Consumer Healthcare by 0.4% in the third quarter. Martingale Asset Management L P now owns 36,971 shares of the company’s stock worth $2,666,000 after buying an additional 140 shares during the last quarter. QRG Capital Management Inc. increased its position in shares of Prestige Consumer Healthcare by 3.3% in the 4th quarter. QRG Capital Management Inc. now owns 5,496 shares of the company’s stock worth $429,000 after purchasing an additional 176 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Prestige Consumer Healthcare by 18.9% in the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock valued at $108,000 after purchasing an additional 220 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of Prestige Consumer Healthcare by 5.9% during the fourth quarter. PNC Financial Services Group Inc. now owns 5,276 shares of the company’s stock worth $412,000 after purchasing an additional 296 shares during the last quarter. Finally, Xponance Inc. lifted its position in shares of Prestige Consumer Healthcare by 10.1% during the fourth quarter. Xponance Inc. now owns 3,570 shares of the company’s stock worth $279,000 after purchasing an additional 328 shares during the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, SVP Mary Beth Fritz sold 1,678 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the sale, the senior vice president now owns 17,157 shares of the company’s stock, valued at $1,544,130. The trade was a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Price Performance

NYSE PBH opened at $85.01 on Friday. The company has a 50-day moving average price of $83.30 and a two-hundred day moving average price of $79.02. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $90.04. The stock has a market cap of $4.21 billion, a price-to-earnings ratio of 19.91, a price-to-earnings-growth ratio of 2.69 and a beta of 0.46. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on PBH shares. Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Oppenheimer raised their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Sidoti lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price for the company. in a research note on Monday, December 9th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Tuesday, March 18th. Finally, Canaccord Genuity Group boosted their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, Prestige Consumer Healthcare currently has an average rating of “Moderate Buy” and an average target price of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.